What dose of cabergoline is needed to be safe and effective when breastfeeding?

Cabergoline (Cabergoline) is a dopamine receptor agonist commonly used to treat hyperprolactinemia and inhibit milk secretion after delivery (i.e., "milk return"). It inhibits the secretion of prolactin (Prolactin) by stimulating dopamine D₂ receptors in the central nervous system, thereby inhibiting lactation. For women who need to resume breastfeeding, cabergoline can effectively inhibit postpartum milk secretion, reduce breast swelling and pain, and prevent the occurrence of mastitis. However, the dosage and use time of the drug must be strictly followed by the doctor's instructions to ensure safety and efficacy.

In cases of postpartum lactation suppression, the generally recommended dose of cabergoline is a single 1 milligram (mg) taken orally, usually within 24 hours after delivery. This dose can effectively inhibit the secretion of prolactin, thereby preventing milk production. If a woman has started to produce milk and has significant breast tenderness, her doctor may recommend taking it in divided doses—for example, 0.25 milligrams every 12 hours for two days. This divided administration method can gently reduce prolactin levels and reduce the discomfort caused by milk secretion. It is especially suitable for women in the middle of lactation or who need to gradually stop breastfeeding.

It should be noted that although cabergoline is powerful, higher doses are not always better. Overdose may cause side effects such as a drop in blood pressure, dizziness, nausea, heart palpitations, or insomnia. In addition, women with high blood pressure, postpartum hemorrhage, or a history of heart valve disease should use cabergoline with special caution and under the supervision of a doctor if necessary. During the medication period, avoid using it at the same time with other antihypertensive drugs or psychotropic drugs to avoid drug interactions.

In general, cabergoline is a highly effective "milk-returning drug" and is relatively safe at the correct dose. It is recommended that women consult an obstetrician or endocrinologist before returning to breastfeeding to clarify their physical condition and the optimal dosage plan. After taking the medicine, you should pay attention to rest, avoid excessive stimulation of the breasts, and drink more water to promote body fluid metabolism. If you experience obvious dizziness, hypotension or abnormal heart rhythm, you should stop taking the medication immediately and seek medical treatment. Only by using cabergoline scientifically and standardizedly can the milk return process be successfully completed while ensuring safety.

Reference materials:https://www.drugs.com/